B-cell markers (e.g., CD79a+, CD20+, Pax-5+) are positive in the infiltrating cells in primary cutaneous marginal zone lymphoma (PCMZL), with Bcl-2 being positive, and Bcl-6 negative. The gene discussed is BCL2; the disease is primary cutaneous marginal zone B-cell lymphoma.